Tratamiento antibiótico precoz para erradicar la infección inicial por Pseudomonas aeruginosa en pacientes con fibrosis quística

Giugno, Hilda; Castaños, Claudio; Lubatti, Alberto; Pinheiro, José Luis; Hernández, Claudia; González Pena, Hebe.
Arch. argent. pediatr ; 108(2): 141-147, abr. 2010. graf
Artigo em Espanhol | LILACS | ID: lil-548757

Documentos relacionados

  1. Pseudomonas aeruginosa virulence attenuation by inhibiting siderophore functions.
  2. Inverse probability weighted estimation for recurrent events data with missing category.
  3. Adaptive Evolution of Pseudomonas aeruginosa in Human Airways Shows Phenotypic Convergence Despite Diverse Patterns of Genomic Changes.
  4. Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future.
  5. Main Metabolites of <i>Pseudomonas aeruginosa</i>: A Study of Electrochemical Properties.
  6. Prognosis and treatment of 46 Chinese pediatric cystic fibrosis patients.
  7. Longitudinal course of clinical lung clearance index in children with cystic fibrosis.
  8. Adaptation to an Amoeba Host Leads to Pseudomonas aeruginosa Isolates with Attenuated Virulence.
  9. <i>Drosophila melanogaster</i> as an organism model for studying cystic fibrosis and its major associated microbial infections.
  10. Serratiopeptidase Affects the Physiology of <i>Pseudomonas aeruginosa</i> Isolates from Cystic Fibrosis Patients.